MeCP2 Reduces MHC I Expression
Author Information
Author(s): Miralvès Julie, Magdeleine Eddy, Kaddoum Lara, Brun Hélène, Peries Sophie, Joly Etienne
Primary Institution: Institut de Pharmacologie et Biologie Structurale, Centre National de la Recherche Scientifique (CNRS), Toulouse, France
Hypothesis
MeCP2 might repress MHC class I expression in the CNS and that this might play a role in the pathology of Rett syndrome.
Conclusion
High levels of MeCP2 may contribute to the repression of MHC expression, but there is no evidence that this regulation is important for the pathogenesis of Rett syndrome.
Supporting Evidence
- Overexpression of MeCP2 downregulated MHC class I expression in neuronal cell lines.
- MeCP2 mutants retained their repressive effect on MHC class I expression.
- Cells from MeCP2 knockout mice showed slightly higher levels of MHC class I compared to wild-type.
Takeaway
The study found that a protein called MeCP2 can lower the levels of certain molecules in brain cells, but this doesn't seem to be the main reason for the problems seen in Rett syndrome.
Methodology
The study involved transfecting neuronal cell lines with MeCP2 and measuring MHC class I expression using flow cytometry.
Limitations
The study could not quantify small variations in MHC class I expression in vivo due to the qualitative nature of immunohistochemistry.
Participant Demographics
The study involved mixed glial cells and fibroblasts from newborn mice.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website